Book2008

Pharmaceutical Pricing Policies in a Global Market

Unknown author

72 citations0/0 files storedOECD health policy studies

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Health Systems, Economic Evaluations, Quality of Life

Abstract

This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 72 citations exist upstream.

References

2003The price of innovation: new estimates of drug development costs 1997Capital-Market Imperfections and Investment 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?2001Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons 2001Technological Innovation in the Pharmaceutical Industry: The Use of Organizational Control in Managing Research and Development 2004Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?1994Perspectives on PPP and Long-Run Real Exchange Rates 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.